1Vision Biogas publishes supplement to the offer document regarding the mandatory cash offer to the shareholders of Biokraft
The Offer is not being made, and this press release may not be released, distributed or published, in whole or in part, directly or indirectly, in or into, nor will any tender of shares be accepted from or on behalf of shareholders in, the United States, Australia, Canada, New Zealand, Hong Kong, Japan, Singapore, South Africa, South Korea, Russia, Belarus or any other jurisdiction in which the making of the Offer, the release, distribution or publication of this press release or the acceptance of any tender of shares would contravene applicable laws or regulations or require further offer documents, filings or other measures in addition to those required under Swedish law. Other restrictions apply. Please refer to the “Important information” at the end of this press release.
Press release
27 February 2024
1Vision Biogas publishes supplement to the offer document regarding the mandatory cash offer to the shareholders of Biokraft
On 2 February 2024, 1Vision Biogas AB (“1Vision Biogas”) announced a mandatory offer to the shareholders of Biokraft International AB (“Biokraft” or the “Company”) to acquire all shares in Biokraft at a price of SEK 20.65 in cash per share (the “Offer”). Biokraft’s shares are listed on Nasdaq First North Premier Growth Market. An offer document regarding the Offer was published on 2 February 2024 (the “Offer Document”) and supplemented on 7 February 2024.
On 26 February 2024, Biokraft published a press release regarding the board of directors’ of Biokraft intention to resolve on share issue to finance the repurchase of its outstanding senior secured green bonds. Further, on 26 February 2024, Biokraft published a statement from the board of directors of Biokraft relating to the Offer, with a fairness opinion from KPMG AB. As a result, 1Vision Biogas has prepared an additional supplement to the Offer Document (the “Supplement Document”) which includes the press release as well as the statement from the board of directors of Biokraft and the fairness opinion from KPMG AB.
The Biokraft board of directors’ opinion is that its recommendation regarding the Offer should be dependent on the shareholder's time horizon for the investment in Biokraft and the shareholder’s risk tolerance as well as their willingness to support the Company’s long-term production targets, which requires additional capital.
In an overall assessment, the board of directors realizes that the Company is currently operating in an uncertain economic environment and that the proposed rights issue and the Company’s operational production targets of at least 1.2 TWh by the end of 2026 and 3 TWh by the end of 2030 will require significant investments from the shareholder to defend their ownership share or a significant dilution of their respective holding. Taking this into account, the board of directors recommends shareholders with a short-term investment horizon and/or a lower risk tolerance as well as those who lack the possibility or willingness to invest additional capital to accept the Offer.
At the same time, the board of directors believes that the terms of the Offer do not reflect the long-term fundamental value of the Company and that shareholders with a long-term investment horizon and/or a higher risk tolerance as well as a willingness to invest additional capital to secure the Company’s funding needs in the proposed rights issue and the Company’s growth journey towards the operational production targets should evaluate the situation carefully and consider retaining their ownership.
The board of directors, however, considers it positive that 1Vision Biogas has shown an interest in the Biogas market in general and Biokraft in particular, and that they have a will to contribute to the Company’s continued development through its industry experience and other resources.
The conclusion in the fairness opinion is that the Offer is not fair from a financial perspective for the shareholders of Biokraft.
The Supplement Document has been published and is, together with the Offer Document, previous supplement document and acceptance form, available on 1Vision Biogas’ website www.1visionbiogas.se and on Danske Bank’s website www.danskebank.se/prospekt. The Supplement Document is only available in Swedish.
The Supplement Document shall be read in conjunction with and constitutes an integral part of the Offer Document and the previous supplement document in all respects.
1Vision Biogas has engaged Danske Bank A/S, Danmark, Sverige Filial as financial adviser and Vinge as legal adviser in connection with the Offer.
Additional information about the Offer is available at www.1visionbiogas.se.
_______________
Further information
For further information, please contact:
Henrikki Talvitie, Chairman of the board of 1Vision Biogas, CEO St1 Nordic Oy,
Henrikki.Talvitie@st1.com
Jan Harald Solstad, member of the board of 1Vision Biogas, Senior Partner HitecVision
Jan.Harald.Solstad@hitecvision.com
This information was submitted for publication on 27 February 2024 at 07:25 CET.
Important information
The Offer is not being made to persons whose participation in the Offer requires that additional offer documents be prepared or registrations effected or that any other measures be taken in addition to those required under Swedish law.
The distribution of this press release and any related offer documentation in certain jurisdictions may be restricted or affected by the laws of such jurisdictions. Accordingly, copies of this communication are not being, and must not be, mailed or otherwise forwarded, distributed or sent in, into or from any such jurisdiction. Therefore, persons who receive this communication (including, without limitation, nominees, trustees and custodians) and are subject to the laws of any such jurisdiction will need to inform themselves about, and observe, any applicable restrictions or requirements. Any failure to do so may constitute a violation of the securities laws of any such jurisdiction. To the fullest extent permitted by applicable law, 1Vision Biogas disclaims any responsibility or liability for the violations of any such restrictions by any person.
The Offer is not being made, and this press release may not be released, distributed or published, in whole or in part, directly or indirectly, in or into, nor will any tender of shares be accepted from or on behalf of shareholders in, the United States, Australia, Canada, New Zealand, Hong Kong, Japan, Singapore, South Africa, South Korea, Russia, Belarus or any other jurisdiction in which the making of the Offer, the release, distribution or publication of this press release or the acceptance of any tender of shares would contravene applicable laws or regulations or require further offer documents, filings or other measures in addition to those required under Swedish law.
The Offer, the information and documents contained in this press release are not being made and have not been approved by an authorised person for the purposes of section 21 of the UK Financial Services and Markets Act 2000 (the “FSMA”). Accordingly, the information and documents contained in this press release are not being distributed to, and must not be passed on to, the general public in the United Kingdom, unless an exemption applies. The communication of the information and documents contained in this press release is exempt from the restriction on financial promotions under section 21 of the FSMA on the basis that it is a communication by or on behalf of a body corporate which relates to a transaction to acquire day to day control of the affairs of a body corporate; or to acquire 50 per cent or more of the voting shares in a body corporate, within article 62 of the UK Financial Services and Markets Act 2000 (Financial Promotion) Order 2005.
Statements in this press release relating to future status or circumstances, including statements regarding future performance, growth and other trend projections and the other benefits of the Offer, are forward-looking statements. These statements may generally, but not always, be identified by the use of words such as “anticipates”, “intends”, “expects”, “believes”, or similar expressions. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. There can be no assurance that actual results will not differ materially from those expressed or implied by these forward-looking statements due to many factors, many of which are outside the control of 1Vision Biogas and Biokraft. Any such forward-looking statements speak only as of the date on which they are made and 1Vision Biogas has no obligation (and undertakes no such obligation) to update or revise any of them, whether as a result of new information, future events or otherwise, except for in accordance with applicable laws and regulations.